Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Exocobio
140
Exocobio
Technology
Biotechnology
Health Care
Medical
Therapeutics
EXOSOME research and developing company which has source technology and patents on commercializing of EXOSOME by cosmeceuticals & biopharmaceuticals
Suggest edits
Founded
2017
Raised
$36.3M
Follow us
Also headquartered in Seoul
SK Telecom
LG Electronics
SK hynix
Samsung SDS
Coupang
10K
Netmarble
Korbit
Coinone
Toss
Companies in the same industry
Storm Therapeutics
Envisagenics, Inc.
Jnana
Prevail Therapeutics
Cryofocus Biotech
panCELLa
Longevity Biotech
Twentyeight-Seven Therapeutics
Carbiotix
Dyno Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$9,300,000
Venture capital (Series C) - 2020
SBI Investment Korea
K2 Investment Partners
Dt & Investment
+3
$27,000,000
Venture capital (Series B) - 2018
KDB Capital
Atinum Investment
InterVest
+6
Team Size
2
Employees
I work here
Location
Seoul
,
South Korea
Headquarters
Explore Seoul
$9,300,000
Venture capital (Series C)
FinSMEs
ExoCoBio Raises $9.3M in Pre-IPO Financing
$27,000,000
Venture capital (Series B)
PE HUB
ExoCoBio takes in $27 mln Series B
FinSMEs
ExoCoBio Raises $26.7M in Series B Funding
Funding
Science
